ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 86 filers reported holding ANTARES PHARMA INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $94,000 | -53.5% | 22,867 | -59.6% | 0.00% | – |
| Q4 2021 | $202,000 | -14.0% | 56,592 | -12.3% | 0.00% | – |
| Q3 2021 | $235,000 | +226.4% | 64,499 | +288.4% | 0.00% | – |
| Q2 2021 | $72,000 | +41.2% | 16,606 | +32.6% | 0.00% | – |
| Q1 2021 | $51,000 | -61.9% | 12,521 | -62.8% | 0.00% | – |
| Q4 2020 | $134,000 | +415.4% | 33,670 | +253.0% | 0.00% | – |
| Q3 2020 | $26,000 | -81.0% | 9,539 | -80.8% | 0.00% | – |
| Q2 2020 | $137,000 | +24.5% | 49,671 | +6.5% | 0.00% | – |
| Q1 2020 | $110,000 | -85.7% | 46,659 | -71.5% | 0.00% | -100.0% |
| Q4 2019 | $770,000 | +1032.4% | 163,921 | +705.8% | 0.00% | – |
| Q3 2019 | $68,000 | -54.4% | 20,342 | -55.0% | 0.00% | – |
| Q2 2019 | $149,000 | +12.9% | 45,161 | +4.2% | 0.00% | – |
| Q1 2019 | $132,000 | +37.5% | 43,321 | +22.1% | 0.00% | – |
| Q4 2018 | $96,000 | -28.4% | 35,467 | -10.7% | 0.00% | – |
| Q3 2018 | $134,000 | +12.6% | 39,695 | -13.2% | 0.00% | – |
| Q2 2018 | $119,000 | +26.6% | 45,737 | +7.5% | 0.00% | – |
| Q1 2018 | $94,000 | +20.5% | 42,543 | +7.8% | 0.00% | – |
| Q4 2017 | $78,000 | +7700.0% | 39,447 | +8627.2% | 0.00% | – |
| Q3 2017 | $1,000 | -66.7% | 452 | -52.3% | 0.00% | – |
| Q2 2017 | $3,000 | -70.0% | 947 | -84.6% | 0.00% | – |
| Q3 2016 | $10,000 | +11.1% | 6,162 | -26.3% | 0.00% | – |
| Q2 2016 | $9,000 | -92.5% | 8,362 | -93.9% | 0.00% | – |
| Q1 2016 | $120,000 | +60.0% | 137,790 | +120.4% | 0.00% | – |
| Q4 2015 | $75,000 | +141.9% | 62,531 | +246.0% | 0.00% | – |
| Q3 2015 | $31,000 | -86.9% | 18,071 | -84.2% | 0.00% | – |
| Q2 2015 | $237,000 | -15.7% | 114,073 | +10.0% | 0.00% | – |
| Q1 2015 | $281,000 | -10.5% | 103,729 | -15.3% | 0.00% | – |
| Q4 2014 | $314,000 | +49.5% | 122,463 | +6.8% | 0.00% | – |
| Q3 2014 | $210,000 | -18.0% | 114,715 | +19.5% | 0.00% | – |
| Q2 2014 | $256,000 | -39.6% | 95,986 | -20.6% | 0.00% | – |
| Q1 2014 | $424,000 | -37.6% | 120,949 | -20.5% | 0.00% | -100.0% |
| Q4 2013 | $680,000 | +69.2% | 152,067 | +53.9% | 0.00% | – |
| Q3 2013 | $402,000 | -1.0% | 98,821 | +1.5% | 0.00% | – |
| Q2 2013 | $406,000 | – | 97,407 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
| Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
| Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
| PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
| Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
| Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
| OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
| FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |